Drug intelligence / Profile preview

oxycodone + lorazepam

Development stage
Unknown
Lead developer
Purdue Pharma
Modality
Small Molecules
Administration
Oral, Intravenous, Intramuscular
01

Overview

Oxycodone + lorazepam is a combination of two pharmaceutical drugs, each with distinct mechanisms of action. Oxycodone is an opioid analgesic used for the management of moderate to severe pain. It acts primarily as an agonist at the mu-opioid receptor, altering the perception and response to pain in the central nervous system. Lorazepam is a benzodiazepine indicated for anxiety disorders, status epilepticus, and as a preanesthetic agent; it works by enhancing the effect of gamma-aminobutyric acid (GABA) at GABA-A receptors in the brain, producing anxiolytic, sedative, anticonvulsant, and muscle relaxant effects. The concurrent use of these agents significantly increases risks due to additive central nervous system depression—most notably profound sedation and respiratory depression—which can be fatal[1][2][4][5]. This combination does not have a unique brand or product name but refers specifically to co-administration or co-prescription.

02

Targets

GABRR (GABA-A receptor subunit rho)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on oxycodone + lorazepam.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oxycodone + lorazepam.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call